RAS mutation status in colorectal cancer
- Date: 20 Apr 2015
- Topic: Colon and Rectal Cancer / Basic Principles in the Management and Treatment (of cancer) / Translational Research
Speaker: Marc Peeters
Marc Peeters interpret results of expanded RAS analysis in the CRYSTAL and OPUS studies in metastatic colorectal cancer and post-hoc analysis of KRAS status in the adjuvant PETACC8 trial.
Discussion Points
- OPUS - Extended RAS analysis
- Do biomarkers have a prognostic role in the adjuvant setting?